公开(公告)号：US20210278421A1

公开(公告)日：2021-09-09

申请号：US17212195

申请日：2021-03-25

Applicant: AJINOMOTO CO., INC.

Inventor： Takeshi IKEUCHI ,  Yuki YANO ,  Hiroko KONDO ,  Wataru SATO ,  Naoko ARASHIDA ,  Satoko UENO ,  Rumi NISHIMOTO ,  Masashi HARADA

IPC: G01N33/68 ,  G16H50/30

Abstract: An evaluating method includes an evaluating step of evaluating a state of mild cognitive impairment for a subject to be evaluated, using (i) at least one value of concentration values of Put, α-ABA, Ala, Arg, Asn, Cit, Glu, Gln, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser, Thr, Trp, Tyr, Val, Taurine, 1-MeHis, 3-MeHis, aAAA, aAiBA, ADMA, Allyl Cys, bABA, bAiBA, Cystathionine, Cysteic acid, EtGly, GABA, hArg, Hypotaurine, Hypro, Kyn, Pyrazole-1-Ala, MCSO, MeCys, N6-AcLys, N8-AcSpd, Opthalmic acid, PEA, Pipecolic acid, Sar, SDMA, Spd, Spm, and Thioproline and test values of Alb, Folate, WBC, RBC, Hb, Ht, and PLT in blood of the subject, or (ii) a value of a formula including an explanatory variable to be substituted with the at least one value, calculated using the at least one value and the formula.